Poster Author Of 4 e-Posters
41 - Association of Use of Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers on LVAD Support and Risk of Gastrointestinal Bleeding: A Multi-Center Analysis
Presentation Number
41
Session Name
SESSION 10 - ORAL: Gastrointestinal Bleeding in MCS Patients
Date
Wed, Apr 22, 2020
Time
02:00 PM - 03:45 PM
Authors
- J. Schultz, Minneapolis, MN, United States of America
- B. Trachtenberg, Houston, TX, United States of America
- J. Estep, Cleveland, OH, United States of America
- K. Goodwin, Minneapolis, MN, United States of America
- R. Araujo, Houston, TX, United States of America
- A. El Rafei, Minneapolis, MN, United States of America
- M. Pritzker, Minneapolis, MN, United States of America
- F. Kamdar, Minneapolis, MN, United States of America
- R. John, Minneapolis, MN, United States of America
- R. Cogswell, Minneapolis, MN, United States of America
42 - Association between Digoxin Use and Gastrointestinal Bleeding in Contemporary Continuous Flow Left Ventricular Assist Device Support
Presentation Number
42
Session Name
SESSION 10 - ORAL: Gastrointestinal Bleeding in MCS Patients
Date
Wed, Apr 22, 2020
Time
02:00 PM - 03:45 PM
Authors
- A. El Rafei, Minneapolis, MN, United States of America
- B. Trachetenberg, Houston, TX, United States of America
- R. John, Minneapolis, MN, United States of America
- J. Estep, Cleveland, OH, United States of America
- J. Schultz, Minneapolis, MN, United States of America
- K. Goodwin, Minneapolis, MN, United States of America
- R. Araujo, Houston, TX, United States of America
- T. Thenappan, Minneapolis, MN, United States of America
- R. Cogswell, Minneapolis, MN, United States of America
66 - External Validation of the Minnesota Pectoralis Muscle Risk Score to Predict Mortality after Ventricular Assist Device Implantation
Presentation Number
66
Session Name
SESSION 17 - ORAL: Patient Selection for LVAD Implantation
Date
Wed, Apr 22, 2020
Time
04:15 PM - 06:00 PM
Authors
- R. Cogswell, Minneapolis, MN, United States of America
- T. Murray, Minneapolis, MN, United States of America
- R. Araujo, Houston, TX, United States of America
- L. Teigen, Minneapolis, MN, United States of America
- B. Trachtenberg, Houston, TX, United States of America
- J. Schultz, Minneapolis, MN, United States of America
- R. John, Minneapolis, MN, United States of America
- C. Martin, Minneapolis, MN, United States of America
- J. Estep, Cleveland, OH, United States of America
303 - Association between Angiotensin II Antagonism and Mortality after LVAD Implantation: A Multi-Center, Contemporary Analysis
Presentation Number
303
Session Name
SESSION 77 - ORAL: Optimal Drug Therapy and Monitoring of MCS Patients
Date
Sat, Apr 25, 2020
Time
12:30 PM - 02:15 PM
Authors
- J. Schultz, Minneapolis, MN, United States of America
- B. Trachtenberg, Houston, TX, United States of America
- J. Estep, Cleveland, OH, United States of America
- K. Goodwin, Minneapolis, MN, United States of America
- R. Araujo, Houston, TX, United States of America
- A. El Rafei, Minneapolis, MN, United States of America
- T. Alexy, Minneapolis, MN, United States of America
- A. Shaffer, Minneapolis, MN, United States of America
- R. John, Minneapolis, MN, United States of America
- R. Cogswell, Minneapolis, MN, United States of America